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Abstract
Although many studies have shown that isoflurane exposure impairs spatial memory in aged animals, there are no clinical
treatments available to prevent this memory deficit. The anticholinergic properties of volatile anesthetics are a biologically
plausible cause of cognitive dysfunction in elderly subjects. We hypothesized that pretreatment with the acetylcholin-
esterase inhibitor donepezil, which has been approved by the Food and Drug Administration (FDA) for the treatment of
Alzheimer’s disease, prevents isoflurane-induced spatial memory impairment in aged mice. In present study, eighteen-
month-old mice were administered donepezil (5 mg/kg) or an equal volume of saline by oral gavage with a feeding needle
for four weeks. Then the mice were exposed to isoflurane (1.2%) for six hours. Two weeks later, mice were subjected to the
Morris water maze to examine the impairment of spatial memory after exposure to isoflurane. After the behavioral test, the
mice were sacrificed, and the protein expression level of acetylcholinesterase (AChE), choline acetylase (ChAT) and a7
nicotinic receptor (a7-nAChR) were measured in the brain. Each group consisted of 12 mice. We found that isoflurane
exposure for six hours impaired the spatial memory of the mice. Compared with the control group, isoflurane exposure
dramatically decreased the protein level of ChAT, but not AChE or a7-nAChR. Donepezil prevented isoflurane-induced
spatial memory impairments and increased ChAT levels, which were downregulated by isoflurane. In conclusions,
pretreatment with the AChE inhibitor donepezil prevented isoflurane-induced spatial memory impairment in aged mice.
The mechanism was associated with the upregulation of ChAT, which was decreased by isoflurane.
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Introduction
Nearly 10–20% of elderly patients suffer from postoperative
cognitive dysfunction (POCD) within 3–6 months after surgery
[1,2]. Although many authors [3,4,5] believe that POCD is self-
limited, POCD is still a major clinical issue. Monk [6] demonstrated
that patientsexperiencingPOCDareatanincreasedriskofdeathin
the first year after surgery. Steinmetz [7] showed that POCD after
noncardiac surgery was associated not only with increased mortality
but also with the risk of leaving the labor market prematurely and
dependency on social transfer payments. However, there is
currently no clinically available treatment to prevent POCD.
Although some studies have not found any differences in the rates of
POCD when comparing regional and general anesthesia [4,5],
exposure to general anesthesia is still considered a possible cause of
POCD in the elderly [8,9]. Many studies have shown that volatile
anestheticsimpairthespatialmemoryofaged rats[10,11];however,
the mechanism is not well understood. Although volatile anesthetics
have been shown to induce apoptosis in cultured cells [12,13], there
is no evidence to prove the relationship between neural apoptosis
and cognitive dysfunction induced by volatile anesthetic exposure in
older animals. Theoretically, the anticholinergic properties of drugs
are a biologically plausible cause of cognitive dysfunction in elderly
subjects. Notably, the anticholinergic drug scopolamine has been
shown to induce or exacerbate preexisting cognitive impairment
[14]. Moreover, three cross-sectional population-based studies have
demonstrated that anticholinergic drug intakeis an important factor
in determining the severity of cognitive impairment [15,16,17].
Because previous studies have shown that volatile anesthetics have
anticholinergic properties [18], we hypothesized that pretreatment
with the acetylcholinesterase inhibitor donepezil, which has been
approved by the Food and Drug Administration (FDA) for the
treatment of Alzheimer’s disease, may prevent isoflurane-induced
spatial memory impairment in aged mice.
Results
Donepezil pretreatment prevented spatial memory
impairment from isoflurane exposure
As showed in Figure 1A, the statistical analyses indicate that the
repeat factor (days) had significant effects on the latency
(p,0.001); the overall group factor also had a significant effect
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animals in the isoflurane exposure group took longer to find the
platform than mice in the isoflurane+donepezil group (p,0.005)
and the control group (p,0.05). However, no interactive effect
between group and days was found (p.0.05).
Statistical analyses showed that on day three and day four,
animals in the isoflurane exposure group took longer to find the
platform (day 3, isoflurane exposure vs. control: p,0.05;
isoflurane exposure vs. isoflurane+donepezil: p,0.05; day 4,
isoflurane exposure vs. control: p,0.05; isoflurane exposure vs.
isoflurane+donepezil: p,0.05). All mice appeared to swim
normally with similar swimming speed, and none of the mice
demonstrated any difficulty in mounting the hidden platform
(Fig. 1B).
Although the percentage time spent in the target quadrant was
significantly longer than the average percentage time spent in
other quadrants for all mice in the probe trial, the time percentage
spent in the target quadrant was similar among the four groups
(Fig. 1C). However, the average proximity to the target for the
mice in the isoflurane group was further away than the average
proximity of the mice in the control group (p,0.05); there was no
difference between the isoflurane+donepezil group and the control
group (Fig. 1D).
Isoflurane exposure decreased choline acetylase protein
levels
Western blotting results showed that isoflurane exposure
dramatically decreased ChAT protein levels (p=0.04). ChAT
protein levels were significantly increased in the donepezil and
donepezil+isoflurane groups compared to the controls (p,0.05 vs.
p,0.05) (Fig. 2A, B). However, there were no differences among
the four groups with regard to AChE or a7-nAChR protein levels
(Fig. 2A, C, D).
Hemodynamics and blood gas analysis
Isoflurane anesthesia may decrease blood pressure and depress
respiration; therefore, we monitored blood pressure and heart rate
during anesthesia. As shown in Figure 3, blood pressure and heart
rate decreased after isoflurane anesthesia, but they remained stable
over the course of the anesthesia. To prevent hypoxia during
isoflurane anesthesia, we analyzed blood gas at the end of the
isoflurane exposure, which revealed normal oxygenation
Figure 1. Donepezil pretreatment prevented spatial memory impairment induced by isoflurane exposure. Following pretreatment
with donepezil or saline, spatial memory was tested with the Morris water maze two weeks after exposure to isoflurane or the carrier gas. A: In spatial
acquisition trials, the mean latency to reach the platform was longer in the isoflurane group compared with the control group (p=0.04) and the
isoflurane+donepezil group (p=0.008). B: Swimming speed was similar among the four groups. C: In the probe trial, the percentage of time spent in
the target quadrant was longer than the average percentage spent in other quadrants (p,0.05) for all four groups, but there were no differences
between the groups for the percentage of time spent in the target quadrant. D: The average proximity to the target in the probe test of the isoflurane
group was further away than the average proximity in the control group (p=0.023). N=12 for each group.
doi:10.1371/journal.pone.0027632.g001
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and moderate acidosis (pH: 7.3060.05).
Discussion
The major finding of the present study was that pretreatment
with the acetylcholinesterase inhibitor donepezil prevented the
spatial memory impairment induced by six hours of isoflurane
(1.2%) exposure. The mechanism of these protective effects may
relate to elevated ChAT levels in the brain. To our knowledge, the
present study is the first demonstration that pretreatment with
donepezil, which has been approved by the FDA for the treatment
of Alzheimer’s disease, prevents isoflurane-induced spatial mem-
ory impairment in aged mice.
Similar to our study, many other reports have shown spatial
memory impairment after isoflurane exposure [11,19,20]. Other
studies have also demonstrated the anticholinergic effects of
isoflurane. Indeed, Grasshoff [21] found that acetylcholine
significantly reduced both the potency and efficacy of isoflurane
on the potential activity of cortical slices from rats. Furthermore,
using cerebral microdialysis, Whittington [22] found that rat
hippocampal acetylcholine (ACh) levels decreased to 36.3613.9%
of baseline levels after an 80-minutes exposure to 1 minimum
alveolar concentration (MAC) of isoflurane. We demonstrated that
levels of ChAT protein, which is the rate-limiting enzyme for the
synthesis of acetylcholine, decreased dramatically two weeks after
isoflurane exposure.
Donepezil, which is an antagonist of AChE, is a clinically
approved medication used to treat Alzheimer’s disease patients
[23]. In the present study, we show that donepezil can prevent
isoflurane-induced spatial memory impairment. This finding
suggests new possibilities for its clinical application to treat
postoperative cognitive dysfunction.
Lee [24] found that animals that received donepezil (0.3 mg/
kg/day, intraperitoneal) had increased ChAT immunoreactivity
in the cerebral cortex, which is similar to the present results. We
demonstrated that intragastric donepezil (5 mg/kg/day) admin-
istration for four weeks increased ChAT levels in the donepezil
group and the donepezil+isoflurane group. However, the MWM
data indicate that donepezil does not make animals in the
isoflurane+donepezil and donepezil groups more clever than the
control mice. The mechanism responsible for these effects is
unknown. Kakinuma [25] found that ChAT levels in the
ventricular myocardium increased after donepezil treatment,
Figure 2. Donepezil pretreatment increased the expression of ChAT which was decreased by isoflurane exposure. A: Isoflurane
exposure decreased ChAT levels, and donepezil increased the expression of ChAT, as detected using Western blotting. B: Statistical analyses
demonstrated significant differences in ChAT expression among the four groups. C: We did not observe any differences in AChE levels among the
four groups. D: In addition, we did not observe any differences in a7-nAChR levels among the four groups. ChAT: choline acetyltransferase; AChE:
acetylcholinesterase; a7-nAChR: a7-nicotinic acetylcholine receptor. N=10 in each group.
doi:10.1371/journal.pone.0027632.g002
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activity. More studies should be performed to determine the
detailed mechanism for these effects. Although Zivin [26] found
that AChE mRNA in the brain increased significantly after 28
days of donepezil treatment (2 mg/kg, subcutaneous), we did
not find any changes in AChE protein levels among the four
groups.
Alpha7-nAChRs are one of the major functional nAChR
subtypes in the brain [27], and these receptors play an important
role in learning and memory [28]. Although Takadatakatori [29]
showed the upregulation of a7-nAChRs in primary culture rat
cortical neurons after chronic donepezil treatment (10 mM, four
days), we did not observe any significant changes in a7-nAChRs
levels between groups. With the two-electrode voltage-clamp
technique, Jackson [22] demonstrated that isoflurane and
halothane inhibited acetylcholine-evoked currents (100 mM) of
a7-nicotinic acetylcholine receptors in Xenopus oocytes in a
reversible and concentration-dependent manner. Studies are
needed to examine a7-nAChRs after donepezil and volatile
anesthetic exposure in vivo.
Six-hour isoflurane exposure in 30% oxygen resulted in stable
blood pressure and heart rate, normal oxygenation, adequate
PCO2 and moderate acidosis. Similarly, Szczesny [30] demon-
strated that 0.8–1.3% isoflurane exposure for 6.5 hours resulted in
a stable mean blood pressure and heart rate in mice. With an
oximeter probe, Ewald [31] found that oxygen saturation
remained at ,97% at anesthesia levels of 0.9%–1.25% isoflurane.
Because it is quite difficult to acquire a sufficient volume of arterial
blood from mice without anesthesia for analysis, there is currently
no record of normal blood gas values for mice. For this reason,
many studies do not assess blood gases [11,19,32,33]. Therefore,
we do not know how to define and evaluate the effects of acidosis
in mice. However, in the present study, no animals died after six
hours of isoflurane exposure, which indicated that even if some
minimum physiological changes occurred, they were of little
clinical relevance.
While this study has provided some interesting data, it also has
limitations. To observe the long-term effects of isoflurane
exposure, we only performed the behavioral and biochemical
tests two weeks after isoflurane exposure, as did other studies
[11,34], thus we do not know the acute effects of isoflurane
exposure in aged mice. Saab [35] found that in adult mice exposed
to 1.3% isoflurane for 1 h, contextual fear memory persisted for
24 hours after isoflurane exposure. Our previous study showed
that repeated isoflurane exposure improved spatial memory [36].
Additional studies are needed to demonstrate the acute effects of
isoflurane on the aged mice. In the present study, we only
performed our behavioral and biochemical tests after donepezil
pretreatment and isoflurane exposure; therefore, more studies
should be performed to assess the causal relationship between the
behavior and alterations in ChAT levels.
The present study used aged mice, but caution should be paid to
transferring the preventative effects of donepezil to other subjects.
Although we demonstrated that donepezil prevented the isoflur-
ane-mediated decrease in ChAT levels, more studies should be
performed before donepezil can be clinically used to treat POCD.
In conclusion, isoflurane (1.2%) exposure for six hours impaired
the spatial memory of aged mice. Donepezil prevented the
isoflurane-induced impairment, which was associated with in-
creasing ChAT levels that were reduced by isoflurane.
Materials and Methods
This study was approved by the Shanghai Jiaotong University
School of Medicine Animal Care and Use Committee(Permit
Number: Renji-09-1010). All procedures were performed in
accordance with the guidelines of the National Institutes of Health
(NIH) for animal care (Guide for the Care and Use of Laboratory
Animals, Department of Health and Human Services, NIH
Publication No. 86-23, revised 1985). Every effort was made to
minimize suffering and the number of animal used.
Animals and anesthetic exposure
The present study used 18-month-old mice (C57BL/6J), which
were raised in the Animal Research Center of Shanghai Jiaotong
University, School of Medicine. All animals were housed in their
home cages, and a standard rodent diet and water were available
ad libitum. Room temperature was maintained at 2261uC, and
relative humidity was set at 50610%. Daily body weights were
recorded for each animal during the experiment, and no changes
were detected throughout the study.
Anesthetic exposure was performed in a chamber that was
partially submerged in a circulating 37uC water bath. A total of
30% oxygen and 70% nitrogen flowed (2 L/min) through a
calibrated isoflurane vaporizer into the chamber. Oxygen, carbon
dioxide and isoflurane concentrations were continually monitored
in the effluent gas chamber using infrared absorbance (Ohmeda
5330, Detex-Ohmeda, Louisville, CO). Rectal temperature was
measured and maintained at a physiological temperature of
37.060.2uC in all groups.
Figure 3. Six-hour isoflurane anesthesia had no significant
effects on blood pressure and heart rate. Separate animals were
used to monitor blood pressure and heart rate. During the six-hour
isoflurane exposure, animals maintained stable heart rates (A) and
stable blood pressure (B).
doi:10.1371/journal.pone.0027632.g003
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Eighteen-month-oldmice were randomly divided into fourgroups:
control, isoflurane, donepezil+isoflurane and donepezil (n=12 in
each group). Mice in the donepezil and donepezil+isoflurane groups
received donepezil (5 mg/kg, Pfizer, NY) by oral gavage with a
feeding needle in 0.5 ml saline every day for four weeks. Mice in the
other two groups received 0.5 ml saline by oral gavage with a feeding
needle. Four weeks later, mice in the donepezil+isoflurane and
isoflurane groups were exposed to 1.2% isoflurane for six hours. Mice
in the donepezil and control groups were exposed to vehicle gas (30%
O2+ 70% N2) for six hours. Two weeks after anesthesia exposure,
mice were subjected to the Morris water maze (MWM) to evaluate
spatial memory. Following the MWM test, the mice were sacrificed,
and brains were removed for Western blot quantitation of
acetylcholinesterase (AChE), choline acetylase (ChAT) and a7
nicotinic receptor (a7-nAChR) protein expression.
Hemodynamic monitor and blood gas analysis
Isoflurane (1.2%) anesthesia was administered for six hours by a
mask that had been specifically designed for use with mice (n=5).
Blood pressure and heart rate were measured before and during
anesthesia (every 30 minutes) with a noninvasive blood pressure
meter (Softron, Beijing, China). At the end of anesthesia, the each
animal’s abdomen was quickly opened, and the abdominal aorta
was exposed. With a 24G venal catheter, 0.5–1 ml blood was
drawn for blood gas analysis.
Morris water maze
The Morris water maze trials were performed by a person
blinded to the group conditions, as previously described [37,38].
The water maze consisted of a painted circular pool (110 cm
diameter and 30 cm high) in which mice were trained to escape
from the water by swimming to a hidden platform (1.5 cm beneath
the water’s surface), the location of which could only be identified
using distal extra-maze cues attached to the room walls. Water was
kept at 20uC and opacified with titanium dioxide for all training
and testing. The pool was divided into four quadrants: north
(Target), south (Opposite), east (Adjacent 1) and west (Adjacent 2).
The experiments were recorded using a camera connected to a
video recorder and a computerized tracking system.
The MWM testing began on the 15
th day after isoflurane
exposure and continued for five days. The first four days were used
for the spatial acquisition phase, which consisted of a total of 16
training trials (four training trials per day and four training days
with an inter-trial interval of 20 minutes). At the beginning of each
trial, the mouse was placed into the water facing the wall of the
pool at one of the four quadrants. Although the starting point was
randomly selected, the protocol was fixed at the beginning of each
trial and was maintained throughout all four acquisition trials.
Each mouse was allowed 90 s to find and mount the platform.
Thirty seconds after the mouse had mounted the platform; the
mouse was removed, placed in a holding cage and warmed with a
heating lamp. Mice that failed to locate and mount the platform
within 90 s were placed on the platform for 30 s before they were
transferred to the holding cage. A video camera mounted above
the pool was used to track the mice. The amount of time spent
finding and mounting the platform (escape latency) and swimming
speed were calculated from the recorded videos using MWM
software (Shanghai Jiliang Software Technology Co. Ltd., China).
On the fifth day (the final day), the mice participated in a probe
trial in which the platform was removed. Mice were allowed to swim
freely for 60 s, and the percentageoftimespent inthe targetquadrant
and the average percentage spent in other quadrants were recorded.
Each individual animal may usea different strategy for looking for the
platform during the probe trial; therefore, we calculated the average
proximity to the former location of the platform from the recording.
Gallagher [39] showed that average proximity to the target was a
more sensitive measure than the time spent in the target quadrant for
Long–Evans rats. Magnusson [40,41] used the average proximity to
measure the spatial memory of aged mice. Sprague [42] used the
proximity score calculated from proximity to evaluate the memory of
aged rats. Their results demonstrated that proximity was suitable to
test the spatial memory of aged rodents.
Western blot analyses
After mice were euthanized using carbon dioxide, their brains
were quickly removed. Each brain was homogenized in RIPA lysis
and extraction buffer (25 mM Tris-HCl, pH 7.6, 150 mM NaCl,
1% NP-40, 1% sodium deoxycholate, 0.1% SDS), which
contained a mixture of phosphatase inhibitors and protease
inhibitors. Protein concentrations were determined using a protein
assay kit (Bio-Rad, Hercules, CA). Protein samples were dissolved
in 26sample loading buffer, denatured at 95uC for 5 minutes and
separated by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) on a 10% gel. An equal amount of protein
from each sample was transferred electrophoretically to nitrocel-
lulose membranes (Amersham Biosciences, Piscataway, NJ). The
membranes were blocked with 5% milk in Tris-buffered saline and
Tween 20 (TBST) for 1 h at room temperature and incubated
overnight at 4uC with rabbit anti-acetylcholinesterase (AChE)
antibody (1:500, Santa Cruz Biotechnology, Inc., Santa Cruz,
CA), goat anti-choline acetyltransferase antibody (1:800, Abcam,
Cambridge, MA), rabbit anti-nicotinic acetylcholine receptor a-7
antibody (1:800, Abcam, Cambridge, MA) or rabbit anti-actin
antibody (1:5,000, Cell Signaling, Danvers, MA) in TBST plus 1%
bovine serum albumin (BSA). After incubation in primary
antibody, the blots were incubated for 1 h at room temperature
with the appropriate horseradish peroxidase (HRP)-conjugated
secondary antibody (anti-rabbit or anti-goat; 1:5000, Santa Cruz
Biotechnology, Inc.) prior to detection with an enhanced
chemiluminescence (ECL) system (Pierce Biotechnology, Rock-
ford, IL). The membranes were then exposed to X-ray film. Four
samples from each group were examined (n=4). ImageJ (NIH free
software) was used to compare the band densities.
Statistics
All data are presented as the mean 6 SEM. Statistical Package
for the Social Sciences (SPSS) v.10.0 software was used for
statistical analyses. Data obtained using Western blotting were
analyzed with one-way analysis of variance (ANOVA) followed by
a least square difference (LSD) multiple comparison test.
Behavioral studies were analyzed using two-way ANOVA with
repeated measures (anesthesia treatment as the between groups
factor and time as the repeated measures factor) followed by
Bonferroni multiple comparison test to compare the four groups.
Differences were considered statistically significant at p,0.05.
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